Clinical Trial Update: ImmeDiate Versus EArLy Invasive Approach in Non-ST-Elevation Myocardial Infarction (IDEAL NSTEMI) [NA]

View source ↗

Summary

The IDEAL NSTEMI trial evaluating immediate versus early invasive management for non-ST-elevation myocardial infarction has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-st-elevation Myocardial Infarction

Snippet

Sponsor: University of Leipzig | Conditions: Non-ST-elevation Myocardial Infarction | NA | Status: WITHDRAWN